Agricultural chemicals and endocrine-mediated chronic toxicity or carcinogenicity

Scandinavian Journal of Work, Environment and Health

Volumn 31, Issue SUPPL. 1, 2005, Pages 141-145

  Barlow, Susan M ^a  

^a Department of Toxicology ^*  (United Kingdom)

Author keywords

Animal; Atrazine; Breast; Cancer; Endometrium; Human; Organochlorine; Pesticide; Prostate; Review; Testis

Indexed keywords

AGRICULTURAL CHEMICAL; ENDOCRINE DISRUPTOR; PESTICIDE;

CANCER; ENDOCRINE SYSTEM; TOXICITY;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CARCINOGENICITY; CHRONIC TOXICITY; CLINICAL OBSERVATION; DISEASE MODEL; ENDOCRINE SYSTEM; ENDOMETRIUM CANCER; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; TESTIS CANCER;

AGROCHEMICALS; ANIMALS; CARCINOGENS; ENDOCRINE DISRUPTORS; HUMANS; TOXICITY TESTS;

ANIMALIA;

EID: 24944483413     PISSN: 03553140     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Colborn T, Clement C. Chemically-induced alterations in sexual and functional development; the wildlife/human connection. Princeton (NJ): Princeton Scientific Publishing Co; 1992.
2. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ, et al. Male reproductive health and environmental chemicals with estrogenic effects. Copenhagen: Danish Environment Protection Agency; 1995.
3. MRC Institute for Environment and Health. IEH assessment on environmental oestrogens: consequences to human health and wildlife. Leicester (UK): MRC Institute for Environment and Health; 1995.
4. German Federal Environment Agency. Endocrine active chemicals in the environment (texte 3/96). Berlin: Umweltbundesamt; 1996.
5. European Commission. European workshop on the impact of endocrine disruptors on human health and wildlife, Weybridge, UK. Brussels: European Commission DG XXI; 1996. Environment and Climate Research Programme, report no EUR 17549.
6. Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaatari S, et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the US EPA sponsored workshop. Environ Health Perspect 1996;104 Suppl 4:715-40.
7. Ankley GT, Johnson RD, Toth G, Folmar LC, Detenbeck NE, Bradbury SP. Development of a research strategy for assessing the ecological risk of endocrine disruptors. Rev Toxicol B Environ Toxicol 1997;1:231-67.
8. US Environmental Protection Agency (US EPA). Special report on environmental endocrine disruption: an effects assessment and analysis. Washington (DC): US EPA; 1997. Report no EPA/630/R-96/012, February (Risk Assessment Forum).
9. National Research Council (NRC). Hormonally active agents in the environment. Washington (DC): NRC, National Academy Press; 1999.
10. Damstra T, Barlow S, Bergman A, Kavlock R, Van der Kraak G, editors. Global assessment of the state-of-the-science of endocrine disruptors. Geneva: International Programme on Chemical Safety (IPCS), World Health Organization; 2002. WHO/PCS/EDC/02.2.
11. Andersen HR, Vinggaard AM, Rasmussen TH, Gjermandsen IM, Bonefeld-Jorgensen EC. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol 2002;179:1-12.
12. Cummings AM, Rhodes BE, Cooper RL. Effect of atrazine on implantation and early pregnancy in 4 strains of rats. Toxicol Sci 2000;58:135-43.
13. Tamura H, Maness SC, Reischmann K, Dorman DC, Gray LE, Gaido KW. Androgen receptor antagonism by the organophosphate insecticide fenitrothion. Toxicol Sci 2001;60:56-62.
14. McIntyre BS, Barlow NJ, Wallace DG, Maness SC, Gaido KW, Foster PM. Effects of in utero exposure to linuron on androgen-dependent reproductive development in the male Crl:CD(SD)BR rat. Toxicol Appl Pharmacol 2000;176:87-9.
15. Commission of the European Communities (CEC). Communication from the Commission to the Council and the Parliament on the implementation of the Community Strategy for Endocrine Disrupters (COM (1999) 706) - a range of substances suspected of interfering with the hormone systems of humans and wildlife. Brussels: CEC; 2001.
16. Shelby MD, Newbold RR, Tully DB, Chae K, Davis VL. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 1996;104:1296-300.
17. Wade MG, Desaulniers D, Leingartner K, Foster WG. Interactions between endosulfan and dieldrin on estrogen-mediated processes in vitro and in vivo. Reprod Toxicol 1997;11:791-8.
18. Ashby J, Lefevre PA, Odum J, Harris CA, Routledge EJ, Sumpter JP. Synergy between synthetic estrogens? Nature1997;385:494.
19. Tennant MK, Hill DS, Eldridge JC, Wetzel LT, Breckenridge CB, Stevens JT. Chloro-s-triazine antagonism of estrogen action: limited interaction with estrogen receptor binding. J Toxicol Environ Health 1994;43:197-211.
20. Conner K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, et al. Failure of chloro-s-triazine derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol 1996;30:93-101.
21. Laws SC, Ferrell JM, Stoker TE, Schmid J, Cooper RL. The effects of atrazine on female Wistar rats: an evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol Sci 2000;58:366-76.
22. Stoker TE, Laws CE, Guidici DL, Cooper RL. The effect of atrazine on puberty in male Wistar rats: an evaluation in the protocol for the assessment of pubertal development and thyroid function. Toxicol Sci 2000;58:50-9.
23. Cooper RL, Stoker TE, Goldman JM, Parrish MB, Tyrey L. Effect of atrazine on ovarian function in the rat. Reprod Toxicol 1996;10:257-64.
24. Cooper RL, Stoker TE, Tyrey L, Goldman JM, McElroy. Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci 2000;58:297-307.
25. Stevens JT, Breckenridge CB, Wetzel LT, Gillis JH, Luempert LG III, Eldridge JC. Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides. J Toxicol Environ Health 1994;43:139-53.
26. Wetzel LT, Luempert III LG, Breckenridge CB, Tisdel MO, Stevens JT, Thakur AK, et al. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley rats and Fischer 344 rats. J Toxicol Environ Health 1994;43:169-82.
27. Vom Saal FS, Finch CE, Nelson JF. Natural history and mechanisms of reproductive aging in humans, laboratory rodents, and other selected vertebrates. In: The physiology of reproduction. 2nd edition. New York (NY): Raven Press; 1994. p 1213-314.
28. Cocco P, Blair A, Congia P, Saba G, Ecca AR, Palmas C. Long-term health effects of the occupational exposure to DDT: a preliminary report. Ann NY Acad Sci 1997;837:246-56.
29. Wassermann M, Nogueira DP, Tomatis L. Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contain Toxicol 1976;15:478-84.
30. Dorgan JF, Brock JW, Rothman N, Needham LL, Miller R, Stephenson HE Jr, et al. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 1999;10:1-11.
31. Hoyer AP, Jorgensen T, Brock JW, Hartvig HB. Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control 2000;11:177-84.
32. Wolff MS, Collman GW, Barrett JC, Huff J. Breast cancer and environmental risk factors: epidemiological and experimental findings. Ann Rev Pharmacol Toxicol 1996;36:573-96.
33. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996;104 Suppl 4:741-76.
34. Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996;88:727-33.
35. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341:1392-5.
36. Cocco P, Benichou J. Mortality from cancer of the male reproductive tract and environmental exposure to the anti-androgen p'p'dichlrodiphenyldichloroethylene in the United States. Oncology 1998;55:334-9.
37. Cook JC, Klinefelter GR, Hardisty JF, Sharpe RM, Foster PM. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms and relevance to humans. Crit Rev Toxicol 1999;29:169-261.
38. Parker SL, Tong T, Bolden S, Wingo RJ. Cancer statistics, 1997. CANADIAN Cancer J Clin 1997;47:5-27.
39. Crisp TM, Clegg ED, Cooper RL, Wood WP, Anderson DG, Baetcke KP, et al. Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect 1998;106 Suppl 1:11-56.
40. Morrison H, Savitz D, Semenciw R, Hulka B, Mao YL, Morrison D, Wigle D. Farming and prostate cancer mortality. Am J Epidemiol 1993;137:270-80.
41. Newbold RR, Banks EP, Bullock B, Jefferson WN. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 2001;61:4325-8.
42. Reuber MD. Carcinogenicity of lindane. Environ Res 1979;19:460-81.
43. Reuber MD. Carcinogenicity and toxicity of methoxychlor. Environ Health Pespect 1980;36:205-19.
44. International Agency for Research on Cancer (IARC). Occupational exposures in insecticide application and some pesticides. Lyon: IARC; 1991. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 53. p 179-250.